Citi Downgrades Novavax (NVAX) to Neutral
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $7.74 --0%
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 35 | New: 4
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 35 | New: 4
Join SI Premium – FREE
Citi downgraded Novavax (NASDAQ: NVAX) from Buy to Neutral.
For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.
Shares of Novavax closed at $8.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Downgrades The Trade Desk (TTD) to Market Perform
- Brean Capital Downgrades First Financial Corp. (THFF) to Neutral
- Kotak Downgrades Firstsource Solutions Ltd (FSOL:IN) to Sell (4)
Create E-mail Alert Related Categories
DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
